Akero Therapeutics (AKRO) had the highest return between August 1, 2022 and September 30, 2022 by a mid-cap US stock, returning 227.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Akero Therapeutics (AKRO) | 8/1/2022 - 9/30/2022 | 227.72% |
Rhythm Pharmaceuticals (RYTM) | 8/1/2022 - 9/30/2022 | 96.79% |
Verona Pharma PLC ADR (VRNA) | 8/1/2022 - 9/30/2022 | 80.25% |
Genius Sports (GENI) | 8/1/2022 - 9/30/2022 | 43.92% |
Weatherford International (WFRD) | 8/1/2022 - 9/30/2022 | 42.88% |
Immunovant (IMVT) | 8/1/2022 - 9/30/2022 | 37.78% |
Palomar (PLMR) | 8/1/2022 - 9/30/2022 | 36% |
Nuvalent (NUVL) | 8/1/2022 - 9/30/2022 | 33.42% |
Wix (WIX) | 8/1/2022 - 9/30/2022 | 32.55% |
Clearwater Analytics (CWAN) | 8/1/2022 - 9/30/2022 | 32.2% |
PureCycle Technologies (PCTTW) | 8/1/2022 - 9/30/2022 | 30.77% |
Immunitybio (IBRX) | 8/1/2022 - 9/30/2022 | 30.45% |
Blueprint Medicines (BPMC) | 8/1/2022 - 9/30/2022 | 30.27% |
Melco Resorts & Entertainment (MLCO) | 8/1/2022 - 9/30/2022 | 29.24% |
Zeta Global (ZETA) | 8/1/2022 - 9/30/2022 | 29.1% |
Catalyst Pharmaceuticals (CPRX) | 8/1/2022 - 9/30/2022 | 25.78% |
MoonLake Immunotherapeutics (MLTX) | 8/1/2022 - 9/30/2022 | 25.57% |
Corporacion America Airports (CAAP) | 8/1/2022 - 9/30/2022 | 25.05% |
Intapp (INTA) | 8/1/2022 - 9/30/2022 | 24.72% |
Shift4 Payments (FOUR) | 8/1/2022 - 9/30/2022 | 24.44% |
Compania de Minas Buenaventura SAA ADR (BVN) | 8/1/2022 - 9/30/2022 | 23.49% |
Transportadora de Gas del Sur SA ADR (TGS) | 8/1/2022 - 9/30/2022 | 23.41% |
PagSeguro Digital (PAGS) | 8/1/2022 - 9/30/2022 | 22.5% |
Apellis Pharmaceuticals (APLS) | 8/1/2022 - 9/30/2022 | 21.99% |
Rumble (RUM) | 8/1/2022 - 9/30/2022 | 21.89% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
